MYRIAD GENETICS INC — Director's Dealing 2015

Aug 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-08-13

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Common Stock	A	58754.0	$0.0	Acquired	77634	Direct

Footnotes

F1: Consists of restricted stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company?s common stock, subject to vesting 25% per year over a four-year period on each anniversary of the date of grant.